PMA device
Thermocool Smarttouch® Sf
Biosense Webster, Inc. · Cardiac Ablation Percutaneous Catheter (LPB, Class III) · First FDA decision Aug 11, 2016, newest Aug 3, 2023Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
16
Naming "Thermocool Smarttouch Sf"
MAUDE reports
1,884
Brand "Thermocool Smarttouch Sf", since 2015
PubMed studies
38
Mentioning "Thermocool Smarttouch Sf"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Thermocool Smarttouch® Sf
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- THERMOCOOL SMARTTOUCH® SFPMA supplement
P040036-S091 · Decided Aug 3, 2023 · 227 days after receipt · Normal 180 Day Track
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- THERMOCOOL SMARTTOUCH SF UNI-DIRECTIONAL NAVIGATION CATHETER; THERMOCOOL SMARTTOUCH SF BI-DIRECTIONAL NAVIGATION CATHETEPMA supplement
P030031-S072 · Decided Aug 11, 2016 · 192 days after receipt · Normal 180 Day Track
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Thermocool Smarttouch Sf", any status and sponsor, newest update first.
Biosense Webster, Inc.Public (JNJ)
NCT06272981 · 136 participants · Start Feb 28, 2024 · Primary completion Oct 28, 2025
Device: Pulsed Field (PF) /Radiofrequency (RF) Catheter ablation · For: Atrial Fibrillation
Sites: Camperdown, Australia; Garran, Australia; Westmead, Australia · 7 sites in all
- Dual Energy Focal Ablation of Premature Ventricular ComplexesNot yet recruiting
Konstantinos SiontisAcademic, hospital or other
NCT07935265 · 60 participants (planned) · Start Jan 2027 · Primary completion Jan 2029
Device: Dual Energy THERMOCOOL SMARTTOUCH™ SF (STSF) Bi-Directional Navigation catheter with TRUPULSE™ Generator · For: Premature Ventricular Contractions
Sites: Rochester, Minnesota
Biosense Webster, Inc.Public (JNJ)
NCT07727057 · 90 participants (planned) · Start Jul 8, 2026 · Primary completion Sep 30, 2027
Device: Radiofrequency/Pulsed Field Ablation System · For: Arrhythmias, Cardiac
Sites: Graz, Austria; Linz, Austria; Aalst, Belgium · 6 sites in all
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Thermocool Smarttouch Sf", and for the whole product code for context.
This brand
1,884 reports: 988 malfunction, 821 injury, 74 death
Whole product code LPB
14,593 reports: 5,424 malfunction, 8,535 injury, 628 death
Newest reports for this brand
- THERMOCOOL SMARTTOUCH SFMalfunction
3013300026-2026-03599 · Received Oct 29, 2026 · Event dated Sep 14, 2026
Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Device problem as coded: Device-Device Incompatibility
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- THERMOCOOL SMARTTOUCH SFMalfunction
3013300026-2026-03606 · Received Oct 29, 2026 · Event dated Jun 19, 2026
Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- THERMOCOOL SMARTTOUCH SFInjury
3013300026-2026-03572 · Received Oct 28, 2026 · Event dated Sep 30, 2026
Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Cardiac Tamponade
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Johnson & Johnson Surgical Vision, Inc.
Z-0169-2023 · Started Sep 7, 2022 · Posted by FDA Nov 2, 2022
Reason given: Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles...
Cause as FDA categorized it: Process control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Z-0139-2015 · Started Oct 19, 2014 · Posted by FDA Oct 27, 2014
Reason given: The recall was initiated because Biosense Webster is providing additional labeling for the safe and effective use of the ThermoCool SmartTouch Catheter.
Cause as FDA categorized it: Use error · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-0979-2012 · Started Nov 22, 2010 · Posted by FDA Feb 7, 2012
Reason given: Biosense Webster, Inc. has recently become aware of the omission of the following two Warning and Precaution statements on the Instructions For Use (IFU) for the above catheter: 1. If phrenic nerve location is a concern, precautionary measures are recommended to evaluate the proximity of the nerve to the ablation...
Cause as FDA categorized it: Labeling design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Thermocool Smarttouch Sf"[tiab]. The summary above synthesizes these.
- Characteristics of tissue temperature during ablation with THERMOCOOL SMARTTOUCH SF versus TactiCath versus QDOT MICRO catheters (Qmode and Qmode+): An in vivo porcine study.
Otsuka N, Okumura Y, Kuorkawa S, et al. · J Cardiovasc Electrophysiol · 2024Research Support, Non-U.S. Gov't
- Evaluating the dual-energy Thermocool SmartTouch SF catheter in the treatment of atrial fibrillation.
Cherbi M, le Polain de Waroux JB, De Smet MAJ, et al. · Future Cardiol · 2026Review
- Evaluation of Ablation Parameters to Predict Irreversible Lesion Size During Pulsed Field Ablation.
Nakagawa H, Farshchi-Heydari S, Maffre J, et al. · Circ Arrhythm Electrophysiol · 2024
- Comparison of the lesion formation and safety in ex vivo porcine heart study: Using ThermoCool SmartTouch and ThermoCool SmartTouch-SF catheters.
Guo M, Qu L, Zhang N, et al. · J Cardiovasc Electrophysiol · 2021Research Support, Non-U.S. Gov't
- Pulsed-field ablation: a breakthrough treatment for atrial fibrillation.
Potter T · Future Cardiol · 2023
- Atrial fibrillation ablation with advanced radiofrequency catheter versus second-generation cryoballoon catheter.
Berman AE, Maccioni S, Khanna R · J Comp Eff Res · 2022Research Support, Non-U.S. Gov't
- Atypical atrial flutter ablation: follow-up and predictors of arrhythmia recurrence.
Micha P, Bartosz K, Kacper R, et al. · Heart Vessels · 2024
- Safety and effectiveness of very-high-power, short-duration ablation in patients with atrial fibrillation: Preliminary results.
Mitrzak K, Peller M, Krzowski B, et al. · Cardiol J · 2024Observational Study
- Persistent Atrial Fibrillation Ablation With Contact Force-Sensing Catheter: The Prospective Multicenter PRECEPT Trial.
Mansour M, Calkins H, Osorio J, et al. · JACC Clin Electrophysiol · 2020Multicenter Study, Research Support, Non-U.S. Gov't
- Acute and mid-term outcomes of ablation for atrial fibrillation with VISITAG SURPOINT: the Japan MIYABI registry.
Okumura K, Inoue K, Goya M, et al. · Europace · 2023Multicenter Study, Observational Study
- Comparison of lesion characteristics using temperature-flow-controlled versus conventional power-controlled ablation with fixed ablation index.
Ikenouchi T, Takigawa M, Goya M, et al. · J Cardiovasc Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Impact of irrigation flow rate and intrapericardial fluid on cooled-tip epicardial radiofrequency ablation.
Aryana A, O'Neill PG, Pujara DK, et al. · Heart Rhythm · 2016Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LPB.
- Therapy Ablation Catheter (4mm and 8mm)Irvine Biomedical, Inc. · PMA 2022
- Navistar ThermocoolBiosense Webster, Inc. · PMA 2014
- EZ Steer ThermoCool CatheterBiosense Webster, Inc. · PMA 2021
- Chilli II Cooled Ablation Catheter and CableBoston Scientific Corp · PMA 2020
- Livewire Tc Ablation Catheter, Safire Ablation CatheterSt Jude Medical · PMA 2016
- Chilli Cooled Ablation SystemBoston Scientific Corp · PMA 2011
- Blazer II Cardiac Ablation System and CableBoston Scientific Corp · PMA 2025
- Freezor Cardiac Cryoablation CatheterMedtronic Cryocath, LP · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.